Coston, McIsaac & Partners »

C4 Therapeutics shares owned by Coston, McIsaac & Partners

Quarter-by-quarter ownership of C4 Therapeutics (CCCC) shares owned by Coston, McIsaac & Partners from 13F filings

Historical chart of Coston, McIsaac & Partners investment in C4 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including C4 Therapeutics held by Coston, McIsaac & Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in C4 Therapeutics by Coston, McIsaac & Partners

Quarter filed Position value Share count Share price at filing
2024-03-31 $0 23 0.00
2023-12-31 $0 19 0.00

More positions owned by Coston, McIsaac & Partners

Dfa Global Equity I Equity Funds (DGEIX)
Vanguard Dividend Appreciation Etf Uit Exchange Traded (VIG)
Berkshire Hathaway Class B Common Stock (BRK.B)
Vanguard Total Stock Market Etf Uit Exchange Traded (VTI)
Williams Sonoma Common Stock (WSM)
Proshares S&p 500 Div Aristocrat Etf Uit Exchange Traded (NOBL)
Apple Common Stock (AAPL)
Vanguard Ftse All World Ex Us Etf Uit Exchange Traded (VEU)
Walmart Common Stock (WMT)
Procter & Gamble Common Stock (PG)
Pepsico Common Stock (PEP)
Mcdonalds Corp Common Stock (MCD)
The Coca-cola Common Stock (KO)
Ingredion Common Stock (INGR)
Johnson & Johnson Common Stock (JNJ)

View all positions for Coston, McIsaac & Partners

Top funds holding C4 Therapeutics

RA Capital Management
Daniel D. Thurber
Commodore Capital
Lynx1 Capital Management
T. Rowe Price Associates
Arrowpoint Asset Management
Vanguard Group
Point72 Asset Management
Soleus Capital Management
Balyasny Asset Management
Bank of America Corporation
Marshall Wace
Millennium Management
Citadel Advisors
Cubist Systematic Strategies

View all funds holding C4 Therapeutics